BNR

BNR

USD

Burning Rock Biotech Limited American Depositary Shares

$2.790-0.120 (-4.124%)

即時價格

Healthcare
Diagnostics & Research
中國

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$2.910

最高

$2.920

最低

$2.790

交易量

0.01M

公司基本面

市值

30.0M

行業

Diagnostics & Research

國家

China

交易統計

平均交易量

0.01M

交易所

NGM

貨幣

USD

52週範圍

最低 $2.62當前 $2.790最高 $8.99

AI分析報告

最後更新: 2025年4月30日
由AI生成數據來源: Yahoo Finance, Bloomberg, SEC

BNR: Burning Rock Biotech Limited - What's Happening and What to Watch

Stock Symbol: BNR Generate Date: 2025-04-30 21:17:31

Alright, let's break down what's been going on with Burning Rock Biotech, ticker symbol BNR, and see what the data might be telling us. Think of this as looking under the hood to figure out the story.

Recent News Buzz: The Financials Hit

The main piece of news we have is from late March, specifically March 25th. Burning Rock put out their unaudited financial results for the fourth quarter and the full year of 2024. Now, just reporting results is pretty standard stuff for a company. But the market's reaction to those results is often the real story.

Looking at the stock's price action right around that March 25th date, something significant happened. The price took a pretty big tumble, and trading volume spiked way up. This suggests that whatever was in those financial results – even though the news headline itself was just factual – was likely seen as negative by investors. When a stock drops sharply on high volume after an earnings report, it usually means the numbers or the outlook weren't what people were hoping for.

Checking the Price Chart: A Steep Slide

Let's look at the stock's journey over the last couple of months. Back in early February, BNR was trading up around the $6 to $7 mark. It even poked its head above $7.50 briefly in mid-February. But since then, it's been a pretty rough ride downhill.

The decline really picked up steam in March, and as we just talked about, there was a particularly sharp drop right after those financial results came out on March 25th. The stock has continued to slide through April, hitting new lows.

Right now, the price is hovering around the $2.90 level. That's really close to its 52-week low, which sits at $2.62. Volume has been relatively low on most days recently, though we've seen a few spikes here and there. The overall trend is clearly down, down, down over the past few months.

What the AI Thinks (and a Head-Scratcher)

We've got some AI predictions for the very near term. The model suggests the price might stay flat today (0.00% change), then see small increases of about 0.9% tomorrow and 1.1% the day after. So, for the next couple of days, the AI is leaning slightly positive, predicting a tiny bounce or stabilization.

Now, here's something a bit confusing from the recommendation data: it mentions the AI projects an "upward trend with potential target price of $1.00". This target price is actually below where the stock is trading right now ($2.92). That's a pretty big inconsistency. It could be a typo, a very long-term pessimistic view mixed in with short-term predictions, or just a glitch in the data. Because it contradicts the short-term percentage predictions and the current price, it's hard to put much stock in that $1.00 target right now. We'll focus more on the day-to-day percentage changes the AI predicts.

The AI prediction score itself is also quite low (13.67 out of 100), which tells us the model isn't super confident in its forecast for this stock.

Putting It All Together: What Now?

So, what's the takeaway from all this?

  1. The Big Picture: Burning Rock's stock has been in a strong downtrend for months, likely made worse by the market's negative reaction to its recent financial results.
  2. Where It Sits Now: The price is currently very low, near its 52-week bottom and a level ($2.90) that the recommendation data flags as potential support or an entry point.
  3. The AI's Short View: The AI model sees a small chance of a slight upward move over the next couple of days, predicting minor percentage gains.
  4. Mixed Signals: The overall recommendation data is quite mixed, even contradictory in places (like the bullish tags vs. bearish technicals and the confusing $1.00 target). This adds to the uncertainty.

Given the steep decline and the price being near potential support and its yearly low, plus the AI's forecast for a tiny short-term uptick, the immediate very short-term situation might look interesting to aggressive traders hoping for a small bounce off the lows. The recommendation system even points to potential entry levels around $2.80 to $2.95.

However, it's absolutely crucial to remember the bigger picture: the strong downtrend, the likely negative financial news that caused the recent big drop, the company's weak fundamentals (losing money, high debt, low growth mentioned in the recommendation reasons), and the high risk factors (high volatility, small size, low volume).

Potential Strategy Ideas (Use Extreme Caution):

  • Leaning: The overall situation leans heavily towards caution or even bearishness based on the trend and fundamentals. However, for someone looking for a potential bounce play, the price being near the 52-week low and flagged support, combined with the AI's tiny positive prediction, could suggest a very short-term 'watch for a bounce' scenario. This is highly speculative, though.
  • Potential Entry Consideration: If someone were considering trying to catch a bounce, the levels around the current price, perhaps targeting the $2.80 to $2.95 area mentioned in the recommendations, might be where they'd look. The idea here would be playing for a quick move up from a heavily beaten-down price.
  • Potential Exit/Stop-Loss Consideration: Managing risk is key here. The recommendation data suggests a stop-loss at $2.60. This makes sense as it's just below the 52-week low. If the price breaks below that, the downtrend is likely continuing hard. For taking profits, the recommendation suggests $3.74, which would be a decent bounce but is still well below where the stock was a couple of months ago.

Quick Company Background

Just to keep in mind, Burning Rock Biotech is a relatively small company in the healthcare sector, specifically focused on using advanced technology (next-generation sequencing) for cancer testing in China. The fact that it's a small company with low trading volume means its price can jump around a lot (high volatility), and it's currently losing money and carrying significant debt, which explains why its fundamentals look weak and contribute to the high risk.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing is risky, and prices can go down as well as up. You should always do your own thorough research, consider your own financial situation and risk tolerance, and consult with a qualified financial advisor before making any investment decisions.

相關新聞

GlobeNewswire

Burning Rock Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results

GUANGZHOU, China, March 25, 2025 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ:BNR, the "Company" or "Burning Rock")), a company focused on the application of next generation sequencing (NGS) technology in

查看更多
Burning Rock Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results

AI預測Beta

AI推薦

看漲

更新於: 2025年5月4日 上午06:43

看跌中立看漲

60.7% 信心度

風險與交易

風險級別4/5
高風險
適合
價值積極
交易指南

入場點

$2.75

獲利了結

$3.28

止損

$2.51

關鍵因素

DMI 顯示熊市趨勢 (ADX:12.6, +DI:16.0, -DI:27.6),建議謹慎
當前價格非常接近支撐位 ($2.84),表明強勁的買入機會
交易量是平均值 (1,463) 的 4.4 倍,表明極強的買入壓力
MACD -0.0200 在信號線 -0.0163 下方,表示看跌交叉

保持更新

設定價格提醒,獲取AI分析更新和即時市場新聞。